Pediatrix (MD) Q1 2026 Earnings Report Summary
Pediatrix (MD) reported Q1 2026 earnings with adjusted EBITDA of $58 million, representing 20% of its full-year guidance range. The company reaffirmed its annual EBITDA guidance of $280 million to $300 million, despite challenges from portfolio restructuring and modest volume declines. Revenue growth was driven by pricing increases and contributions from non-same-unit sources.
Tickers: $MD
Topics: cash flow earnings EBITDA guidance revenue share repurchases